EX-10.17 18 a2217789zex-10_17.htm EX-10.17 [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities...Development and License Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Development and License Agreement (“AGREEMENT”) is made effective as of March 18, 2008 (the “EFFECTIVE DATE”) by and between Robert One, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“ROBERT”), and Eagle Pharmaceutical, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). ROBERT and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • December 20th, 2013 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 20th, 2013 Company Industry JurisdictionThis DEVELOPMENT AND LICENSE AGREEMENT (this “AGREEMENT”) is made as of February 13, 2009 (the “EFFECTIVE DATE”) by and between Robert One, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“ROBERT”), and Eagle Pharmaceuticals, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). ROBERT and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • December 20th, 2013 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 20th, 2013 Company Industry JurisdictionThis Development and License Agreement (“AGREEMENT”) is made effective as of March 18, 2008 (the “EFFECTIVE DATE”) by and between Robert One, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“ROBERT”), and Eagle Pharmaceutical, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). ROBERT and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • November 25th, 2013 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 25th, 2013 Company Industry JurisdictionThis DEVELOPMENT AND LICENSE AGREEMENT (this “AGREEMENT”) is made as of February 13, 2009 (the “EFFECTIVE DATE”) by and between Robert One, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“ROBERT”), and Eagle Pharmaceuticals, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). ROBERT and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • November 25th, 2013 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 25th, 2013 Company Industry JurisdictionThis Development and License Agreement (“AGREEMENT”) is made effective as of March 18, 2008 (the “EFFECTIVE DATE”) by and between Robert One, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“ROBERT”), and Eagle Pharmaceutical, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). ROBERT and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”